Published in Arch Dermatol on April 01, 1978
Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science (1998) 12.81
Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol (1999) 6.66
Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med (1997) 6.13
Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J Virol (1997) 3.93
Carpal dislocations: pathomechanics and progressive perilunar instability. J Hand Surg Am (1980) 3.89
Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruses (1996) 3.74
Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. J Immunol (1998) 3.65
Seat belt usage: A potential target for applied behavior analysis. J Appl Behav Anal (1980) 3.59
Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology (1994) 3.18
A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus. J Virol (1997) 3.10
Identification of highly attenuated mutants of simian immunodeficiency virus. J Virol (1998) 2.94
Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J Virol (1996) 2.85
Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J Exp Med (1994) 2.81
Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat Med (1999) 2.77
Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J Exp Med (1994) 2.72
Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J Virol (1999) 2.65
Vero cytotoxigenic Escherichia coli infection in dairy farm families. J Infect Dis (1996) 2.56
Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity (2000) 2.53
The form and function of the sieve tube: a problem in reconciliation. Int Rev Cytol (1968) 2.26
Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J Clin Invest (1998) 2.15
Assembly of focal adhesions: progress, paradigms, and portents. Curr Opin Cell Biol (1996) 2.07
Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. J Virol (1998) 1.94
Increased rates of CD4(+) and CD8(+) T lymphocyte turnover in simian immunodeficiency virus-infected macaques. Proc Natl Acad Sci U S A (1998) 1.88
An animal model for acute and persistent Epstein-Barr virus infection. Science (1997) 1.85
Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol (1987) 1.81
Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc (1985) 1.77
Characterization of gut-associated lymphoid tissue (GALT) of normal rhesus macaques. Clin Immunol Immunopathol (1997) 1.74
Detection of 16 gamma-ray pulsars through blind frequency searches using the Fermi LAT. Science (2009) 1.74
Distribution of core oligosaccharide types in lipopolysaccharides from Escherichia coli. Infect Immun (2000) 1.59
Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIV. J Virol (1998) 1.59
Epicuticular wax in the stomatal antechamber of sitka spruce and its effects on the diffusion of water vapour and carbon dioxide. Planta (1971) 1.56
Persistence of Escherichia coli O157:H7 in dairy cattle and the dairy farm environment. Epidemiol Infect (1997) 1.51
Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus. J Virol (2000) 1.47
The acutely injured wrist and its residuals. Clin Orthop Relat Res (1980) 1.43
Differential dynamics of CD4(+) and CD8(+) T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection. J Virol (2000) 1.43
Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus. J Exp Med (1998) 1.39
Development of a Head Scanner for Proton CT. Nucl Instrum Methods Phys Res A (2012) 1.39
The Fermi Gamma-Ray Space Telescope discovers the pulsar in the young galactic supernova remnant CTA 1. Science (2008) 1.39
Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells. Proc Natl Acad Sci U S A (1997) 1.38
Fermi observations of high-energy gamma-ray emission from GRB 080916C. Science (2009) 1.37
Quantification of thymic function by measuring T cell receptor excision circles within peripheral blood and lymphoid tissues in monkeys. Eur J Immunol (2000) 1.35
Addicted physicians. A closer look. JAMA (1981) 1.34
Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. J Immunol (1993) 1.32
Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques. J Virol (1996) 1.31
Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J Immunol (1992) 1.31
Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type 1-infected persons in the presence of combination antiretroviral agents. J Infect Dis (1995) 1.30
Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1. J Virol (1999) 1.28
Emergence and kinetics of simian immunodeficiency virus-specific CD8(+) T cells in the intestines of macaques during primary infection. J Virol (2001) 1.27
Induction of mucosal homing virus-specific CD8(+) T lymphocytes by attenuated simian immunodeficiency virus. J Virol (2000) 1.25
Escherichia coli O157:H7 diarrhoea associated with well water and infected cattle on an Ontario farm. Epidemiol Infect (1998) 1.24
Live attenuated AIDS vaccines: hazards and hopes. Nat Med (1999) 1.24
A population of gamma-ray millisecond pulsars seen with the Fermi Large Area Telescope. Science (2009) 1.24
Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production. Proc Natl Acad Sci U S A (1999) 1.23
Sooty mangabeys and rhesus macaques exhibit significant divergent natural killer cell responses during both acute and chronic phases of SIV infection. Cell Immunol (2008) 1.23
Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1. J Clin Invest (1997) 1.21
A limit on the variation of the speed of light arising from quantum gravity effects. Nature (2009) 1.20
Identification of regions affecting virulence, RNA processing and infectivity in the virulent satellite of turnip crinkle virus. EMBO J (1988) 1.19
Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents. J Clin Microbiol (1996) 1.18
Definition of the Mamu A*01 peptide binding specificity: application to the identification of wild-type and optimized ligands from simian immunodeficiency virus regulatory proteins. J Immunol (2000) 1.17
Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection. Eur J Immunol (2001) 1.17
HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons. AIDS Res Hum Retroviruses (1994) 1.15
Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. J Infect Dis (1996) 1.15
Capsular polysaccharide antigens for detection of serotype-specific antibodies to Actinobacillus pleuropneumoniae. Can J Vet Res (1990) 1.12
Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition. J Virol (1997) 1.12
Xanthomatosis of the central nervous system. Clinical and pathological observations of a case with a posterior fossa syndrome. Neurology (1970) 1.11
The conduction of sap : II. Detection of vibrations produced by sap cavitation in Ricinus xylem. Planta (1966) 1.09
Painful spondylolysis or spondylolisthesis studied by radiography and single-photon emission computed tomography. Radiology (1985) 1.09
Protective local and systemic antibody responses of swine exposed to an aerosol of Actinobacillus pleuropneumoniae serotype 1. Infect Immun (1992) 1.09
Olecranon fractures treated with AO screw and tension bands. Orthopedics (1986) 1.07
Chronic knee pain assessed by SPECT: comparison with other modalities. Radiology (1985) 1.07
Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2. Gene Ther (1996) 1.05
Studies of the stability of 18 chemical constituents of human serum. Clin Chem (1972) 1.04
Characterization of lymphocyte subsets in rhesus macaques during the first year of life. Eur J Haematol (2000) 1.02
The ligaments of the human wrist and their functional significance. Anat Rec (1976) 1.01
Phenotypic and genotypic characterization of Escherichia coli verotoxin-producing isolates from humans and pigs. J Food Prot (2001) 1.01
Mechanisms associated with thymocyte apoptosis induced by simian immunodeficiency virus. J Immunol (2000) 1.01
Identification of multiple simian immunodeficiency virus (SIV)-specific CTL epitopes in sooty mangabeys with natural and experimentally acquired SIV infection. J Immunol (2000) 1.00
Escherichia coli O157:H7 infection in cows and calves in a beef cattle herd in Alberta, Canada. Epidemiol Infect (2002) 1.00
Detection of femoral head avascular necrosis in adults by SPECT. J Nucl Med (1985) 1.00
Comparison of Vero cell assay and PCR as indicators of the presence of verocytotoxigenic Escherichia coli in bovine and human fecal samples. Appl Environ Microbiol (1996) 0.98
Detection of high-energy gamma-ray emission from the globular cluster 47 Tucanae with Fermi. Science (2009) 0.96
200 MeV proton radiography studies with a hand phantom using a prototype proton CT scanner. IEEE Trans Med Imaging (2014) 0.96
Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides. Gene Ther (2008) 0.95
Constraining dark matter models from a combined analysis of Milky Way satellites with the Fermi Large Area Telescope. Phys Rev Lett (2011) 0.95
Gamma-ray emission concurrent with the nova in the symbiotic binary V407 Cygni. Science (2010) 0.95
Serodiagnosis of pleuropneumonia using enzyme-linked immunosorbent assay with capsular polysaccharide antigens of Actinobacillus pleuropneumoniae serotypes 1, 2, 5 and 7. Can J Vet Res (1990) 0.95
Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: dependence on TAP1/2 and mechanisms for cytosolic localization. J Immunol (1999) 0.95
Vaccination with SIVmac239Deltanef activates CD4+ T cells in the absence of CD4 T-cell loss. J Med Primatol (2009) 0.94
Fermi large area telescope measurements of the diffuse gamma-ray emission at intermediate galactic latitudes. Phys Rev Lett (2009) 0.94
Enhanced laser-driven ion acceleration in the relativistic transparency regime. Phys Rev Lett (2009) 0.93
Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning. Blood (1999) 0.93
Host range and lytic capability of four bacteriophages against bovine and clinical human isolates of Shiga toxin-producing Escherichia coli O157:H7. J Appl Microbiol (2009) 0.92
Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual. J Immunol (1998) 0.92